Dana Farber Cancer Institute SC-12
Boston, Massachusetts 02115
We've found
1 trials
at this facility
ALK-positive Non-small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
